Pradžia › Autoimuninės ligos › Ilinoisas › Chicago
Autoimuninės ligos klinikiniai tyrimai Chicago, IL
12 tyrimai dėl Autoimuninės ligos ieško dalyvių vietose Chicago ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.
Oficialus tyrimo tekstas (anglų kalba)
Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →
A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
Renkami dalyviai2 fazė
- University of Chicago, Chicago
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Renkami dalyviai2/3 fazė
- Ann & Robert H. Lurie Children's Hospital of Chicago - Accepting Young Adult and Juvenile Patients, Chicago
- Northwestern Memorial Hospital - Accepting Adult Patients, Chicago
- The University of Chicago Medical Center - Accepting Adult and Juvenile Patients, Chicago
Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
Renkami dalyviai2 fazė
- University of Chicago, Department of Medicine: Rheumatology, Chicago
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Renkami dalyviai1 fazė
- The University of Chicago Medical Center, Chicago
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Renkami dalyviai1/2 fazė
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
Renkami dalyviai1/2 fazė
- University of Illinois Hospital & Health Sciences System, Chicago
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Renkami dalyviai2/3 fazė
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
Renkami dalyviai1/2 fazė
- Northwestern Memorial Hospital, Chicago
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Renkami dalyviaiStebimasis tyrimas
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
- University of Illinois at Chicago, Chicago
- ir dar 2
Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
Renkami dalyviai1 fazė
- Northwestern University, Chicago
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
Renkami dalyviai1/2 fazė
- Northwestern University, Chicago
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
- University of Chicago Medical Center, Chicago
Autoimuninės ligos tyrimai kituose miestuose
- Houston, TX21 tyrimas
- Washington, DC19 tyrimai
- New York City, NY19 tyrimai
- Philadelphia, PA16 tyrimai
- Durham, NC15 tyrimai
- Boston, MA13 tyrimai
- Los Angeles, CA12 tyrimai
- Dallas, TX9 tyrimai
- Cleveland, OH8 tyrimai
- Milwaukee, WI8 tyrimai
- Atlanta, GA8 tyrimai
- Portland, OR8 tyrimai
Kiti tyrimai Chicago
- Nedidelinių ląstelių plaučių vėžys61 tyrimas
- Krūties vėžys58 tyrimai
- Vėžys (visų tipų)51 tyrimas
- Metastatinis vėžys45 tyrimai
- Prostatos vėžys45 tyrimai
- Nutukimas41 tyrimas
- Plaučių vėžys41 tyrimas
- Kiaušidžių vėžys36 tyrimai
- Insultas34 tyrimai
- Storosios ir tiesiosios žarnos vėžys33 tyrimai
- Širdies nepakankamumas31 tyrimas
- Antsvoris28 tyrimai
Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.